Your session is about to expire
← Back to Search
Non-pharmacological Therapy
Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy
N/A
Waitlist Available
Led By Simon Conti, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study (day 3 to 10)
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a TENS device, which uses gentle electrical pulses to relieve pain, on patients who have pain from a ureteral stent after surgery. The goal is to see if it can reduce their pain and nausea, and also lessen the need for narcotic painkillers.
Eligible Conditions
- Kidney Stones
- Kidney stones
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ end of study (day 3 to 10)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study (day 3 to 10)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Difference in Pain on 11-point Visual Analog Score Scale (VAS)
Pain on 11-point Visual Analog Score Scale (VAS)
Secondary study objectives
Difference in Total Opioid Consumption
Patient Satisfaction Survey
Total Opioid Consumption
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TENS deviceExperimental Treatment1 Intervention
Participants will use the TENS device until the ureteral stent is removed
Group II: Standard careActive Control1 Intervention
Participants will follow standard care until the ureteral stent is removed
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TENS
2011
Completed Phase 2
~2040
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,484 Previous Clinical Trials
17,516,080 Total Patients Enrolled
Simon Conti, MDPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are pregnant.You are currently undergoing a procedure called percutaneous nephrolithotomy (PCNL).You are currently having a procedure called laser lithotripsy, but you will not have a stent placed during the procedure.You have an implantable stimulator.You are an adult patient who will be receiving standard treatment for urinary stone disease, which involves ureteroscopy and laser lithotripsy.The trial is not open to children.You are currently undergoing treatment for a urologic cancer using a procedure called ureteroscopy.You have epilepsy.You need a ureteral stent for a long time or on a regular basis.
Research Study Groups:
This trial has the following groups:- Group 1: Standard care
- Group 2: TENS device
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.